Novartis' breast cancer treatment wins FDA approval

The U.S. Food and Drug Administration (FDA) said on Friday that it had approved Novartis AG's treatment in combination with a hormone therapy for postmenopausal women, as well as for men, with a form of advanced breast cancer.

from Reuters: Health https://reut.rs/2EspOjm
via IFTTT

• Tweet
• Share
• Share
• Share
• Share